Le Tourneau C - Search Results

1

Current challenges for the early clinical development of anticancer drugs in the era of molecularly targeted agents.

Le Tourneau C, Diéras V, Tresca P, Cacheux W, Paoletti X. Le Tourneau C, et al. Target Oncol. 2010 Mar;5(1):65-72. doi: 10.1007/s11523-010-0137-6. Epub 2010 Apr 2. Target Oncol. 2010. PMID: 20361265 Review.

2

[Phase I cancer trials methodology].

Le Tourneau C, Faivre S, Raymond E, Diéras V. Le Tourneau C, et al. Bull Cancer. 2007 Nov;94(11):943-51. Bull Cancer. 2007. PMID: 18055311 Free article. French.

3

Reports of clinical benefit of plitidepsin (Aplidine), a new marine-derived anticancer agent, in patients with advanced medullary thyroid carcinoma.

Le Tourneau C, Faivre S, Ciruelos E, Domínguez MJ, López-Martín JA, Izquierdo MA, Jimeno J, Raymond E. Le Tourneau C, et al. Am J Clin Oncol. 2010 Apr;33(2):132-6. doi: 10.1097/COC.0b013e318199fb6e. Am J Clin Oncol. 2010. PMID: 19687728 Clinical Trial.

4

Choice of starting dose for molecularly targeted agents evaluated in first-in-human phase I cancer clinical trials.

Le Tourneau C, Stathis A, Vidal L, Moore MJ, Siu LL. Le Tourneau C, et al. J Clin Oncol. 2010 Mar 10;28(8):1401-7. doi: 10.1200/JCO.2009.25.9606. Epub 2010 Feb 1. J Clin Oncol. 2010. PMID: 20124167 Review.

5

Phase I evaluation of seliciclib (R-roscovitine), a novel oral cyclin-dependent kinase inhibitor, in patients with advanced malignancies.

Le Tourneau C, Faivre S, Laurence V, Delbaldo C, Vera K, Girre V, Chiao J, Armour S, Frame S, Green SR, Gianella-Borradori A, Diéras V, Raymond E. Le Tourneau C, et al. Eur J Cancer. 2010 Dec;46(18):3243-50. doi: 10.1016/j.ejca.2010.08.001. Epub 2010 Sep 6. Eur J Cancer. 2010. PMID: 20822897 Clinical Trial.

6

Development of anti-cancer drugs.

Arrondeau J, Gan HK, Razak AR, Paoletti X, Le Tourneau C. Arrondeau J, et al. Among authors: le tourneau c. Discov Med. 2010 Oct;10(53):355-62. Discov Med. 2010. PMID: 21034677 Free article. Review.

7

[Molecularly targeted therapy in head and neck cancer].

Le Tourneau C. Le Tourneau C. Bull Cancer. 2010 Dec;97(12):1453-66. doi: 10.1684/bdc.2010.1226. Bull Cancer. 2010. PMID: 21134823 Free article. Review. French.

8

Role of chemotherapy and molecularly targeted agents in the treatment of adenoid cystic carcinoma of the lacrimal gland.

Le Tourneau C, Razak AR, Levy C, Calugaru V, Galatoire O, Dendale R, Desjardins L, Gan HK. Le Tourneau C, et al. Br J Ophthalmol. 2011 Nov;95(11):1483-9. doi: 10.1136/bjo.2010.192351. Epub 2010 Dec 22. Br J Ophthalmol. 2011. PMID: 21183517 Review.

9

[Dose finding methods for targeted agents: new perspectives].

Paoletti X, Postel-Vinay S, Servois V, Doussau A, Ollivier L, Le Tourneau C. Paoletti X, et al. Among authors: le tourneau c. Bull Cancer. 2010 Dec;97(12):1485-95. doi: 10.1684/bdc.2010.1232. Bull Cancer. 2010. PMID: 21220226 Free article. Review. French.

10

Targeted biotherapy in metastatic colorectal carcinoma: Current practice.

Cacheux W, Le Tourneau C, Baranger B, Mignot L, Mariani P. Cacheux W, et al. Among authors: le tourneau c. J Visc Surg. 2011 Feb;148(1):12-8. doi: 10.1016/j.jviscsurg.2010.12.004. Epub 2011 Jan 28. J Visc Surg. 2011. PMID: 21277276 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

262 results

Search Page